MedPath
HSA Product

VENOFER SOLUTION FOR INJECTION 100 mg/5 ml

Product approved by Health Sciences Authority (SG)

Basic Information

VENOFER SOLUTION FOR INJECTION 100 mg/5 ml

INJECTION

Regulatory Information

SIN11354P

July 20, 2000

Prescription Only

Therapeutic

INTRAVENOUS

August 10, 2023

June 3, 2025

XB03AC

Company Information

VIFOR PHARMA ASIA PACIFIC PTE. LTD.

VIFOR PHARMA ASIA PACIFIC PTE. LTD.

Active Ingredients

IRON EQV IRON SUCROSE

Strength: 100 mg/5 ml

Detailed Information

Contraindications

**4.3 Contraindications** The use of Venofer is contraindicated in the following conditions: - Hypersensitivity to iron sucrose, Venofer or to any of its excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_ - Anaemia not caused by iron deficiency - Evidence of iron overload or disturbances in utilisation of iron - Pregnancy first Trimester

Indication Information

**4.1 Therapeutic indications** Venofer is indicated for the treatment of iron deficiency in the following indications: - Where there is a clinical need for a rapid iron supply - In patients who cannot tolerate oral iron therapy or who are non-compliant - Where oral iron preparations are ineffective (e.g., in active inflammatory bowel disease) Venofer should only be administered where the indication is confirmed by appropriate investigations.

© Copyright 2025. All Rights Reserved by MedPath